Trial Profile
Phase I/II, Non-randomized trial of panobinostat in patients with latent HIV-1 infection
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 17 Jul 2015
Price :
$35
*
At a glance
- Drugs Panobinostat (Primary)
- Indications HIV-1 infections
- Focus Biomarker; Therapeutic Use
- 17 Jul 2015 New trial record